Kusajili – Clinical trials directory

Result of your search per sponsor: Novartis Investigator Site

Woman and Man Max 99 years
Novartis Investigator Site Update Il y a 5 ans

Efficacy, Safety, and Tolerability of Once Daily Indacaterol in Chronic Obstructive Pulmonary Disease (COPD) Using Formoterol Twice Daily as Active Control This study was designed to assess the efficacy and long-term safety of 300 and 600 µg doses of indacaterol when delivered via a single-dose dry-powder inhaler (SDDPI) in patients with chro...

Country None
organs None
Specialty None

Closed trial

More information